Skip to content

Evaluation of the effects of Trigonella foenum graecum seed extract on patients with myocardial infarction

Evaluation of the effects of Trigonella foenum graecum seed extract on the hs-CRP level in patients with myocardial infarction

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220516054874N9
Enrollment
60
Registered
2023-07-06
Start date
2023-07-23
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial infarction. ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction

Interventions

Intervention 1: Intervention group: Patients with myocardial infarction receiving Trigonella foenum graecum seed extract (335 mg, prepared by Barij essence company) twice a day for one month along wit

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with myocardial infarction according to the American College of Heart criteria Consent to admission to the study Age more than 18 years old

Exclusion criteria

Exclusion criteria: Kidney failure under hemodialysis Severe liver failure with liver enzymes three times more than normal History of allergy to Trigonella foenum graecum or peas History of using medicinal products containing Trigonella foenum graecum seed extract

Design outcomes

Primary

MeasureTime frame
Changes in hs-CRP serum level. Timepoint: At the beginning of the study and after 4 weeks of treatment. Method of measurement: Laboratory kit.

Secondary

MeasureTime frame
Changes in CBC diff. Timepoint: At the beginning of the study and after 4 weeks of treatment. Method of measurement: Laboratory kit.;Changes in lipid profile. Timepoint: At the beginning of the study and after 4 weeks of treatment. Method of measurement: Laboratory kit.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Vafa Baradaran Rahimi

Mashhad University of Medical Sciences

baradaranrv@mums.ac.ir0095 5138012739

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026